0000905718-21-001615.txt : 20211215 0000905718-21-001615.hdr.sgml : 20211215 20211215212956 ACCESSION NUMBER: 0000905718-21-001615 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211214 FILED AS OF DATE: 20211215 DATE AS OF CHANGE: 20211215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jabbour Jerome D CENTRAL INDEX KEY: 0001698838 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38022 FILM NUMBER: 211495778 MAIL ADDRESS: STREET 1: C/O MATINAS BIOPHARMA HOLDINGS, INC. STREET 2: 1545 ROUTE 206, SUITE 302 CITY: BEDMINSTER STATE: NJ ZIP: 07921 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Matinas BioPharma Holdings, Inc. CENTRAL INDEX KEY: 0001582554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463011414 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1545 ROUTE 206 SOUTH STREET 2: SUITE 302 CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: 908-484-8805 MAIL ADDRESS: STREET 1: 1545 ROUTE 206 SOUTH STREET 2: SUITE 302 CITY: BEDMINSTER STATE: NJ ZIP: 07921 4 1 matinas_fm4dec142021.xml X0306 4 2021-12-14 0 0001582554 Matinas BioPharma Holdings, Inc. MTNB 0001698838 Jabbour Jerome D C/O MATINAS BIOPHARMA HOLDINGS, INC. 1545 ROUTE 206, SUITE 302 BEDMINSTER NJ 07921 1 1 0 0 President and CEO Stock Option (right to Buy) 0.92 2021-12-14 4 A 0 1658100 0 A 2031-12-13 Common Stock 1658100 1658100 D The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on December 14, 2022 with the remaining shares to vest in equal monthly installments on the last day of each month over a period of 36 months commencing December 31, 2022. /s/ Keith A. Kucinski 2021-12-15